在肝细胞癌中,非ATPase 6的26S蛋白酶子单元的过度表达模式,功能和临床价值
Sheng-Sheng Zhou1, Yu-Ping Ye2, Yi Chen3
1Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
World journal of clinical oncology
|February 25, 2025
概括
蛋白质素26S亚单元非ATPase 6 (PSMD6) 在肝细胞癌 (HCC) 中过度表达,导致瘤生长. 这项研究揭示了PSMD6.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 蛋白质酶26S子单元非ATPase6 (PSMD6) 与各种癌症有关.
- 它在肝细胞癌 (HCC) 中的作用仍然未被探索.
研究的目的:
- 研究PSMD6在HCC中的表达模式和临床意义.
- 阐明PSMD6在HCC发育中的功能作用和分子机制.
主要方法:
- 来自HCC和非HCC组织的大规模mRNA和蛋白质表达数据的综合分析.
- 利用CRISPR-Cas9淘汰技术评估HCC细胞系中的PSMD6功能.
- 进行功能丰富分析和药物敏感性测试.
主要成果:
- 在HCC组织中,PSMD6在mRNA和蛋白质水平上显著过度表达.
- 绝杀PSMD6抑制了HCC细胞的增殖.
- 丰富分析表明它参与了核糖体生物发生和RNA剪接.
- 高PSMD6表达与药物耐药性相关,可以区分HCC组织.
结论:
- PSMD6是一种在HCC中过度表达的新型瘤基因.
- PSMD6对HCC细胞生长至关重要,可能成为潜在的治疗点.
关键词:
聚类有规律间隔的短palindromic重复.肝细胞癌是肝细胞癌.蛋白质组26S子单元非ATPase 6的ATPase 6通过RNA拼接进行RNA拼接.核糖体生物生成 (Ribosome Biogenesis) 是一个过程.更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.2K
10:26Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
5.5K
相关概念视频
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
The Proteasome Structure
676
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
676
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
